It was a pleasure to catch up with our Editorial Board member Prof. Farhad Hafezi (ELZA Institute, Zurich, Switzerland), the winner of the ESCRS 2020 Refractive Award! Here he discusses the PACK-CXL multicentre trial, and the benefits of this treatment.
- What are the major challenges in the treatment of infectious keratitis? (00:15)
- Could you give us a brief overview of the photoactivated chromophore for keratitis-corneal collagen cross-linking (PACK-CXL) treatment and its advantages compared to standard protocols? (01:57)
- Could you tell us about the PACK-CXL multicentre trial, including the major findings? (03:51)
Speaker Disclosures: Prof. Farhad Hafezi holds patents and applications fo corneal apparatus used for CXL, chromophore for CXL application; and is a shareholder and investor for EMAGine AG.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of ESCRS 2020.
Share this Video
Related Videos In Corneal Disorders
Farhad Hafezi, ESCRS 2021: Epithelium-on Cross-linking at the Slit Lamp
We were delighted to catch up with Farhad Hafezi (ELZA Institute, Zurich, Switzerland) about the disadvantages of performing corneal cross-linking procedures in the operating theatre, the potential to now perform epithelium-on cross-linking procedures at the slit lamp, and the implication of this on future practice. Questions Could you give us an overview of epithelium-on cross-linking […]
Farhad Hafezi, ESCRS 2021: Development of an Effective Epithelium-on Procedure
It was great to speak with Farhad Hafezi (ELZA Institute, Zurich, Switzerland) about the recent advances that have made an epithelium-on corneal cross-linking procedure possible. Question Why has it taken so long to develop an effective epithelium-on procedure (00:13) Speaker Disclosure: Farhad Hafezi holds patents and applications for corneal apparatus used for CXL, chromophore for […]
Sumit Garg, ASCRS 2021: Pterygia – Selection of Adjunctive Modalities and Unmet Needs
We were delighted to speak with Sumit Garg (Gavin Herbert Eye Institute, University of California, Irvine, CA, USA) about the factors that influence selection of the adjunctive modalities conjunctival autograft, adjunctive amniotic membrane transplantation or intraoperative mitomycin C, for an individual patient, as well as unmet needs and future outlook. Questions What factors influence the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!